TipRanks

Kathryn Jean Boor Insider Profile

11 Followers
Kathryn Jean Boor, Director at Sarepta Therapeutics, holds 25.14K shares in Sarepta Therapeutics (Ticker: SRPT), holds 255.00 shares in International Flavors & Fragrances (Ticker: IFF).
tipranks
Kathryn Jean Boor

Kathryn Jean Boor
Sarepta Therapeutics (SRPT)
Director

Ranked #33,936 out of 109,232 Corporate Insiders

Profitable Transactions

100%
2 out of 2 Profitable Transactions

Average Return

+49.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$479K
95.50%
4.50%
A breakdown of Kathryn Jean Boor's holdings

Insider Roles

Sarepta Therapeutics
(SRPT)
Director
International Flavors & Fragrances
(IFF)
Director
Roles that Kathryn Jean Boor holds in companies

Most Profitable Insider Trade

Stock:
Sarepta Therapeutics
(SRPT)
Rating:Informative Sell
Date:Dec 06, 2024 - Dec 06, 2025
Return:+82.60%
The most profitable trade made by Kathryn Jean Boor

Kathryn Jean Boor's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Sarepta Therapeutics
Jun 05, 2026
Director
Uninformative Buy
―
$457.76K
International Flavors & Fragrances
May 07, 2021
Director
Uninformative Buy
37.36K
$21.59K
List of latest transactions for each holding click on a transaction to see Kathryn Jean Boor's performance on stock

Kathryn Jean Boor insider profile FAQ

What is the percentage of profitable transactions made by Kathryn Jean Boor?
The percentage of profitable transactions made by Kathryn Jean Boor is 100%.
    What is the average return per transaction made by Kathryn Jean Boor?
    The average return per transaction made by Kathryn Jean Boor is 49.80%.
      What stocks does Kathryn Jean Boor hold?
      Kathryn Jean Boor holds: SRPT, IFF stocks.
        What was Kathryn Jean Boor’s latest transaction?
        Kathryn Jean Boor latest transaction was an Uninformative Buy of ―.
          What was Kathryn Jean Boor's most profitable transaction?
          Kathryn Jean Boor’s most profitable transaction was an Informative Sell of SRPT stock on December 6, 2024. The return on the trade was 82.60%.
            What is Kathryn Jean Boor's role in Sarepta Therapeutics?
            Kathryn Jean Boor's role in Sarepta Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.